INBS Stock: Intelligent Bio Solutions Inc. Stock Price, Analysis & Insights
Get live inbs stock price $9.53, comprehensive Intelligent Bio Solutions Inc. stock analysis, charts, news, and expert forecast. Real-time inbs stock data and investment insights.
Loading chart...
Company Overview
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Company Information
- CEO
- Harry Simeonidis
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 50
Contact Information
- Website
- https://gbs.inc
- Address
- 142 West 57th Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 4.51)
Business Model & Strategy
Intelligent Bio Solutions Inc. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Harry Simeonidis, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Intelligent Bio Solutions Inc. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 6.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Intelligent Bio Solutions Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Intelligent Bio Solutions Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Intelligent Bio Solutions Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Intelligent Bio Solutions Inc.
- ⚠Investors should consider how Intelligent Bio Solutions Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
6.15M
P/E Ratio
-0.58
Beta
4.51
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 6.15M market capitalization
- Trading Volume: 106.02M shares traded today
- Price Range: 52-week range of $4.03 - $27.50
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (INBS) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 6.15M, the company represents a significant player in its market. The stock is currently trading at $9.53 with a positivedaily change of 132.44%.
The company's 50 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.58, beta of 4.51, and 52-week price range from $4.03 to $27.50when evaluating investment opportunities.
Why Invest in Intelligent Bio Solutions Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Harry Simeonidis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.